Digital Diabetes Management Global Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the global digital diabetes management market owing to the wide acceptance of technologically advanced solutions such as closed-loop control systems, rising adoption of diabetes management remote online coaching services, connected diabetes management apps. Moreover, favorable reimbursement policies, raising awareness, government initiatives to promote digital health, and aggressive strategic adopted by players such as product launch, merger & acquisition, and partnership in this region also fueling the growth of digital diabetes management market. For instance, in November 2018, Nutrino has been acquired by Medtronic plc that strengthened Medtronic's portfolio in the digital diabetes management Industry.
The European market is expected to be the second-largest digital diabetes management market. The market growth in this region can be attributed to the government support for research & development and availability of funds for research.
Asia-Pacific is expected to be the fastest-growing digital diabetes management market during the forecast period owing to the rising number of the diabetes patient, increasing investments in healthcare and expansions by market players in the region. Moreover, countries such as India and China are considering the fastest growing region due to the presence of a huge patient population. Moreover, the government of these countries is open to adopting new technology and the best treatment option from a developed country. According to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes will be the 7th leading cause of death by 2030.
The market in the Middle East & Africa is expected to account for the smallest share of the global digital diabetes management market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Some of the key players in the global digital diabetes management market are
Global Digital Diabetes Management Market, by Type
Global Digital Diabetes Management Market, by Product and Service
Global Digital Diabetes Management Market, by End User
Global Digital Diabetes Management Market, by Region
|Market Size||2030: USD 86.6 Billion|
|CAGR||2022-2030: 24.10 %|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Product and Service, End User And Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Abbott Laboratories, Agamatrix, Inc., Ascensia Diabetes Care Holdings Ag., B. Braun Melsungen AG, Dariohealth Corporation, Dexcom, Inc., F. Hoffmann-La Roche, Glooko, Inc., Insulet Corporation, Lifescan, Inc., Medtronic PLC, Tandem Diabetes Care, Inc., Tidepool, and others|
|Key Market Opportunities||Adopting new technology and the best treatment option from a developed country|
|Key Market Drivers||The growing prevalence of diabetes is the major driver for the market.|
Frequently Asked Questions (FAQ) :
The Type of devices included in the Digital Diabetes Management Market are Wearable Devices, Handheld Devices.
The market is expected to exhibit a strong 20.8% CAGR over the forecast period from 2022 to 2030.
The growing prevalence of diabetes is the major driver for the market.
North America is the leading regional market, followed by Europe.
Leading players in the digital diabetes management market include B. Braun Melsungen, Abbott, F. Hoffman-La Roche, Agamatrix Inc., and Glooko, among others.
The global digital diabetes management market was valued at more than USD 4.4 billion in 2017.